Retinoic Acid Receptor, beta (RARB) (N-Term) Peptide
Quick Overview for Retinoic Acid Receptor, beta (RARB) (N-Term) Peptide (ABIN5511495)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Sequence
- EKALKACFSG LTQTEWQHRH TAQSIETQST SSEELVPSPP SPLPPPRVYK
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-RARB Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- Retinoic Acid Receptor beta (RARB) (Retinoic Acid Receptor, beta (RARB))
-
Background
-
This gene encodes retinoic acid receptor beta, a member of the thyroid-steroid hormone receptor superfamily of nuclear transcriptional regulators. This receptor localizes to the cytoplasm and to subnuclear compartments. It binds retinoic acid, the biologically active form of vitamin A which mediates cellular signalling in embryonic morphogenesis, cell growth and differentiation. It is thought that this protein limits growth of many cell types by regulating gene expression. The gene was first identified in a hepatocellular carcinoma where it flanks a hepatitis B virus integration site. The gene expresses at least two transcript variants, one additional transcript has been described, but its full length nature has not been determined.
Protein Size: 448 -
Gene ID
- 5915
Target
-